A cross-stream analysis of 76 research and 45 corporate records finds that the science is moving to e-fuels while the money converts refineries to HEFA, and that four techniques, including CO2-to-fuel catalysis, have research activity and no corporate record.
Tags: Sustainable Aviation Fuel · EFuels · HEFA · Aviation Decarbonization
A cross-stream analysis of 280 research and 107 corporate records finds that generative design is the only contested technique, 75 research mentions against 74 corporate, while Insilico Medicine’s rentosertib has entered Phase III and buyers pay upfronts of just 1.2 to 2.7 percent of headline deal value.
Tags: AIDesigned Molecules · AIDrug Discovery · Protein Design · Validation Data
Researchers at the Centre for Genomic Regulation combined mouse model experiments with human patient datasets to identify six genes whose combined activity predicts acute myeloid leukemia survival more accurately than PHF19 alone.
Tags: Acute Myeloid Leukemia · PHFScore · Cancer Prognosis · Precision Oncology
University of Maryland researchers recording 64-electrode EEG from participants wearing a Meta Quest 2 headset found statistically significant decreases in frontal high-frequency and occipital low-frequency brain waves during cybersickness caused by vergence-accommodation conflict.
Tags: Virtual Reality · Cybersickness · EEG · Neurotech
An analysis of 1,270 AI-mentioning records among 4,840 corporate records finds that AI is associated with the biggest momentum gains in announcements that lack other evidence, such as product updates at 9.7 percent against 2.1 percent, while physical AI reaches 41.5 percent High momentum and computer vision none.
Tags: AIAnnouncements · AILabel · Physical AI · Agentic AI
Luxembourg Institute of Health researchers used patient-derived glioblastoma organoid co-cultures with human T cells to show that local cell-to-cell contact, not MHC-I loss, drives T-cell suppression, creating a patient-relevant platform for testing immunotherapy combinations.
Tags: Glioblastoma · Immunotherapy · Neuro Oncology · Organoid Models
An analysis of 673 monetary figures in 4,840 corporate records finds that headline numbers overstate transactions several times over, while records carrying a real transaction show High momentum 34.8 percent of the time against 10.8 percent for the rest.
Tags: Capital Investment Signal · Venture Capital · Funding Stages · Acquisitions
A text scan of 4,840 corporate records finds that a date doubles the weight of an announcement, yet only 4.9 percent of records commit to one, and 166 of the 236 dated commitments point to 2026 or 2027, giving a catalyst calendar from Q4 2026 to 2030.
Tags: Forward Guidance · Dated Commitments · Catalyst Calendar · Capacity Buildout
BioOrbit’s six-week Baby BOX-E mission achieved the largest-scale production of protein crystals in a space environment to date, supporting a route from hospital infusion to at-home injection for cancer therapies.
Tags: Space Biotechnology · Protein Crystallization · Cancer Therapeutics · In Space Manufacturing
An analysis of 2,041 partnered announcements and 13,384 co-announcement links finds that partnerships committing supply, data or clinical capacity carry 19.0 to 23.1 percent High momentum against 11.0 percent for distribution deals, while Microsoft, Google, NVIDIA, OpenAI, Amazon and Anthropic form the network’s hubs.
Tags: Partnership Ecosystem · Joint Ventures · Platform Hubs · Licensing Deals